J Stroke.  2023 May;25(2):303-306. 10.5853/jos.2023.00297.

Genotype–Phenotype Correlation of the RNF213 R4810K Variant in Moyamoya Disease

Affiliations
  • 1Department of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, Korea
  • 2Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 3Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul, Korea


Figure

  • Figure 1. Association of postoperative collateral development and the RNF213 R4810K variant in moyamoya disease. The caliber change ratios for the superficial temporal artery were compared between patients with the RNF213 R4810K variant and those with the wild-type variant. RNF213, ring finger protein 213; GG, wild type; GA, heterozygote; AA, homozygote.


Cited by  1 articles

Moyamoya disease: insights into the clinical implications of the RNF213 gene
Taedong Ok
Cardiovasc Prev Pharmacother. 2024;6(4):109-115.    doi: 10.36011/cpp.2024.6.e14.


Reference

References

1. Bang OY, Fujimura M, Kim SK. The pathophysiology of moyamoya disease: an update. J Stroke. 2016; 18:12–20.
Article
2. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011; 6:e22542.
3. Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, et al. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg. 2016; 124:1221–1227.
Article
4. Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012; 78:803–810.
Article
5. Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016; 18:2–11.
Article
6. Ge P, Ye X, Liu X, Deng X, Wang R, Zhang Y, et al. Association between p. R4810K variant and long-term clinical outcome in patients with moyamoya disease. Front Neurol. 2019; 10:662.
7. Nomura S, Yamaguchi K, Akagawa H, Kawashima A, Moteki Y, Ishikawa T, et al. Genotype-phenotype correlation in long-term cohort of Japanese patients with moyamoya disease. Cerebrovasc Dis. 2019; 47:105–111.
Article
8. Kim WH, Kim SD, Nam MH, Jung JM, Jin SW, Ha SK, et al. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism. Childs Nerv Syst. 2019; 35:309–314.
Article
9. Kawabori M, Ito M, Kazumata K, Tokairin K, Hatanaka KC, Ishikawa S, et al. Impact of RNF213 c.14576G>A variant on the development of direct and indirect revascularization in pediatric moyamoya disease. Cerebrovasc Dis. 2022; Sep. 5. [Epub]. https://doi.org/10.1159/000526089.
Article
10. Wen J, Sun X, Chen H, Liu H, Lai R, Li J, et al. Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish. Brain Res. 2016; 1644:70–78.
Article
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr